NCT06380842

Brief Summary

The purpose of this study is to characterize organ dysfunction change in acute necrotizing pancreatitis patients with sepsis after open necrosectomy.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
200

participants targeted

Target at P75+ for all trials

Timeline
8mo left

Started Jun 2024

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress75%
Jun 2024Dec 2026

First Submitted

Initial submission to the registry

March 26, 2024

Completed
29 days until next milestone

First Posted

Study publicly available on registry

April 24, 2024

Completed
2 months until next milestone

Study Start

First participant enrolled

June 15, 2024

Completed
2.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 30, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2026

Last Updated

September 23, 2025

Status Verified

September 1, 2025

Enrollment Period

2.5 years

First QC Date

March 26, 2024

Last Update Submit

September 18, 2025

Conditions

Keywords

Acute Necrotizing Pancreatitissepsisorgan dysfunction

Outcome Measures

Primary Outcomes (1)

  • Measure organ dysfunction change after open necrosectomy with respect to time

    Organ dysfunction will be measured using sequential organ failure assessment score scale. The scores range from 0 (normal) to 4(most abnormal) for each organ, with higher scores indicating worse health status

    up to postoperative day 7, or at hospital discharge, whichever comes first

Secondary Outcomes (11)

  • incidence of a composite of major complications

    up to postoperative day 28

  • Incidence of ICU mortality

    through study completion, an average of 1year

  • Incidence of hospital mortality

    through study completion, an average of 1 year

  • Incidence of 28-day mortality

    through study completion, an average of 1 year

  • Incidence of one year mortality

    through study completion, an average of 1 year

  • +6 more secondary outcomes

Study Arms (1)

Pancreatitis with sepsis patients' organ dysfunction progression after open necrosectomy

Acute necrotizing pancreatitis patients with sepsis undergoing open necrosectomy will be measured SOFA scores at a special time point to characterize organ dysfunction experience profiles.

Other: Necrotizing Pancreatitis patients' organ dysfunction progression

Interventions

Study the dynamic nature of organ dysfunction

Pancreatitis with sepsis patients' organ dysfunction progression after open necrosectomy

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Acute necrotizing pancreatitis Patients with sepsis scheduled for open necrosectomy will be invited to participate in this study.

You may qualify if:

  • Patients 18 years or older
  • Diagnosis of Acute pancreatitis according to the revised Atlanta classification, requires two of the following three criteria: (A) typical abdominal pain, (B) an increase in serum amylase or lipase levels higher than three times the upper limit of normality, and (C) signs of AP in imaging
  • Patients with confirmed or suspected infected pancreatic or peripancreatic necrosis were scheduled for open necrosectomy
  • Meet Sepsis-3 criteria

You may not qualify if:

  • Patients refuse to participate
  • Patients undergo repeat surgery on the same site

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

West China Hospital, Sichuan University

Chengdu, China, 610041, China

RECRUITING

MeSH Terms

Conditions

Pancreatitis, Acute NecrotizingSepsis

Condition Hierarchy (Ancestors)

PancreatitisPancreatic DiseasesDigestive System DiseasesInfectionsSystemic Inflammatory Response SyndromeInflammationPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Fengming Luo, PhD

    West China Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

March 26, 2024

First Posted

April 24, 2024

Study Start

June 15, 2024

Primary Completion (Estimated)

December 30, 2026

Study Completion (Estimated)

December 30, 2026

Last Updated

September 23, 2025

Record last verified: 2025-09

Data Sharing

IPD Sharing
Will not share

Locations